Fluoroquinolone Resistance in Mycobacterium tuberculosis: The Effect of Duration and Timing of Fluoroquinolone Exposure
AUTOR(ES)
Devasia, Rose A.
FONTE
American Thoracic Society
RESUMO
Rationale: Fluoroquinolones are the most commonly prescribed antibiotic class in the United States. They have the potential to become first-line antituberculosis therapy, but the effect of fluoroquinolone use on fluoroquinolone resistance in Mycobacterium tuberculosis is not well characterized.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2731810Documentos Relacionados
- Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance
- Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective
- Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations.
- Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance.
- Drug resistance in Mycobacterium tuberculosis: a survey over 25 years in Blackburn.
